| Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease FE Dewey, V Gusarova, RL Dunbar, C O’Dushlaine, C Schurmann, ... New England Journal of Medicine 377 (3), 211-221, 2017 | 757 | 2017 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 714 | 2021 |
| A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease NS Abul-Husn, X Cheng, AH Li, Y Xin, C Schurmann, P Stevis, Y Liu, ... New England Journal of Medicine 378 (12), 1096-1106, 2018 | 676 | 2018 |
| Biobank-driven genomic discovery yields new insight into atrial fibrillation biology JB Nielsen, RB Thorolfsdottir, LG Fritsche, W Zhou, MW Skov, SE Graham, ... Nature genetics 50 (9), 1234-1239, 2018 | 588 | 2018 |
| Genetics of blood lipids among~ 300,000 multi-ethnic participants of the Million Veteran Program D Klarin, SM Damrauer, K Cho, YV Sun, TM Teslovich, J Honerlaw, ... Nature genetics 50 (11), 1514-1523, 2018 | 555 | 2018 |
| Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study FE Dewey, MF Murray, JD Overton, L Habegger, JB Leader, SN Fetterolf, ... Science 354 (6319), aaf6814, 2016 | 547 | 2016 |
| Computationally efficient whole-genome regression for quantitative and binary traits J Mbatchou, L Barnard, J Backman, A Marcketta, JA Kosmicki, ... Nature genetics 53 (7), 1097-1103, 2021 | 529 | 2021 |
| Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis M Vujkovic, JM Keaton, JA Lynch, DR Miller, J Zhou, C Tcheandjieu, ... Nature genetics 52 (7), 680-691, 2020 | 506 | 2020 |
| Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease FE Dewey, V Gusarova, C O’Dushlaine, O Gottesman, J Trejos, C Hunt, ... New England Journal of Medicine 374 (12), 1123-1133, 2016 | 494 | 2016 |
| Exome sequencing and analysis of 454,787 UK Biobank participants JD Backman, AH Li, A Marcketta, D Sun, J Mbatchou, MD Kessler, ... Nature 599 (7886), 628-634, 2021 | 443 | 2021 |
| Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations HR Kranzler, H Zhou, RL Kember, R Vickers Smith, AC Justice, ... Nature communications 10 (1), 1499, 2019 | 430 | 2019 |
| Genetic identification of familial hypercholesterolemia within a single US health care system NS Abul-Husn, K Manickam, LK Jones, EA Wright, DN Hartzel, ... Science 354 (6319), aaf7000, 2016 | 419 | 2016 |
| The power of genetic diversity in genome-wide association studies of lipids SE Graham, SL Clarke, KHH Wu, S Kanoni, GJM Zajac, S Ramdas, ... Nature 600 (7890), 675-679, 2021 | 393 | 2021 |
| Exome sequencing and characterization of 49,960 individuals in the UK Biobank CV Van Hout, I Tachmazidou, JD Backman, JD Hoffman, D Liu, ... Nature 586 (7831), 749-756, 2020 | 389 | 2020 |
| Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls J Flannick, JM Mercader, C Fuchsberger, MS Udler, A Mahajan, J Wessel, ... Nature 570 (7759), 71-76, 2019 | 278 | 2019 |
| Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank JD Szustakowski, S Balasubramanian, E Kvikstad, S Khalid, PG Bronson, ... Nature genetics 53 (7), 942-948, 2021 | 276 | 2021 |
| Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations CG Boer, K Hatzikotoulas, L Southam, L Stefánsdóttir, Y Zhang, ... Cell 184 (18), 4784-4818. e17, 2021 | 275 | 2021 |
| Whole-genome sequencing reveals host factors underlying critical COVID-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature 607 (7917), 97-103, 2022 | 220 | 2022 |
| Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants KG Aragam, T Jiang, A Goel, S Kanoni, BN Wolford, DS Atri, EM Weeks, ... Nature genetics 54 (12), 1803-1815, 2022 | 201 | 2022 |
| Exome sequencing–based screening for BRCA1/2 expected pathogenic variants among adult biobank participants K Manickam, AH Buchanan, MLB Schwartz, MLG Hallquist, JL Williams, ... JAMA Network Open 1 (5), e182140-e182140, 2018 | 197 | 2018 |
Jeffrey ReidRegeneron PharmaceuticalsVerified email at regeneron.com
